Virtu Financial’s Black Diamond Therapeutics BDTX Stock Holding History

Virtu Financial’s Portfolio BDTX Stock Details BDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$42K	Buy	+22,716	New	+$55.6K	﹤0.01%	1243
2025 Q4	–	Sell	-10,415	Closed	-$39K	–	1675
2025 Q3	$39K	Buy	+10,415	New	+$30.5K	﹤0.01%	1169
2022 Q4	–	Sell	-10,703	Closed	-$18K	–	1612
2022 Q3	$18K	Buy	+10,703	New	+$33K	﹤0.01%	1416
2022 Q1	–	Sell	-22,664	Closed	-$121K	–	1499
2021 Q4	$121K	Buy	+22,664	New	+$158K	0.01%	1048

Other funds holding BDTX

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Virtu Financial's BDTX Position: Q2 2026 in Review

Virtu Financial opened a new position in Black Diamond Therapeutics (BDTX) in Q2 2026: 22,716 shares worth $42K. The stake represents ﹤0.01% of the portfolio and ranks #1243 among its holdings. This is a return to the name: Virtu Financial previously reported a position in BDTX as recently as Q3 2025.

Virtu Financial first reported a position in BDTX in Q4 2021 and has held it in 4 quarters since. The position peaked at $121K in Q4 2021. 96 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

Virtu Financial held 22,716 shares of Black Diamond Therapeutics worth $42K as of Q2 2026.
Black Diamond Therapeutics was a new Virtu Financial position in Q2 2026.
Black Diamond Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1243 holding.
Virtu Financial first reported a position in Black Diamond Therapeutics in Q4 2021 and has held it in 4 quarters since.
Virtu Financial's Black Diamond Therapeutics position peaked at $121K in Q4 2021.
96 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.